GNOCCHI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 129
AS - Asia 123
SA - Sud America 21
EU - Europa 13
AF - Africa 7
Totale 293
Nazione #
US - Stati Uniti d'America 123
CN - Cina 49
SG - Singapore 26
BR - Brasile 15
HK - Hong Kong 13
IT - Italia 7
MY - Malesia 6
TH - Thailandia 6
VN - Vietnam 5
TN - Tunisia 4
CA - Canada 3
ID - Indonesia 3
IQ - Iraq 3
CL - Cile 2
CO - Colombia 2
NL - Olanda 2
PH - Filippine 2
PK - Pakistan 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CR - Costa Rica 1
FR - Francia 1
GB - Regno Unito 1
HU - Ungheria 1
IN - India 1
LB - Libano 1
LK - Sri Lanka 1
MX - Messico 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
TR - Turchia 1
UA - Ucraina 1
Totale 293
Città #
San Jose 94
Ashburn 19
Singapore 18
Hong Kong 12
Beijing 9
Bangkok 5
Kuala Selangor 3
Jakarta 2
Kuala Lumpur 2
Riyadh 2
Santa Clara 2
Santiago 2
São Paulo 2
Amstelveen 1
Baghdad 1
Batavia 1
Bogotá 1
Buriti dos Montes 1
Cachoeiras de Macacu 1
Cagliari 1
Cape Town 1
Caraguatatuba 1
Châteauguay 1
Colombo 1
Courbevoie 1
Da Nang 1
Duhok 1
Durban 1
Farnborough 1
Fort Mill 1
Fort Worth 1
Ho Chi Minh City 1
Islamabad 1
Istanbul 1
Jdaidet el Matn 1
Jenin 1
Kolomyia 1
Manila 1
Mardan 1
Medellín 1
Mexico City 1
Milan 1
Nabeul 1
Naples 1
Nasiriyah 1
New Britain 1
Ninh Bình 1
Nossa Senhora do Socorro 1
Oakville 1
Palmas 1
Panama City 1
Patrocínio 1
Paulista 1
Petaling Jaya 1
Phoenix 1
Pioltello 1
Pune 1
Queimados 1
Recife 1
Rio de Janeiro 1
Rome 1
San José 1
San Pablo 1
Santa Rita 1
Santana de Parnaíba 1
Saskatoon 1
Sharjah 1
Sorocaba 1
Sousse 1
Tangerang 1
Teboulbou 1
Thái Bình 1
Triunfo 1
Tunis 1
Tân Tiến 1
Zafferana Etnea 1
Totale 235
Nome #
Diiodothyronines regulate metabolic homeostasis in primary human hepatocytes by modulating mTORC1 and mTORC2 activity 21
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy 16
Circadian rhythms and hormonal homeostasis: Pathophysiological implications 16
Crithmum maritimum extract exerts broad antitumor activity by reprogramming energy metabolism in cancer cells 14
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function 12
3,5,3'-triiodothyronine (T3) stimulates cell proliferation through the activation of the PI3K/Akt pathway and reactive oxygen species (ROS) production in chick embryo hepatocytes 12
Lipotoxicity of palmitic acid is associated with DGAT1 downregulation and abolished by PPARα activation in liver cells 11
Oleic acid but not fructose induces steatosis and insulin resistance in primary adult and fetal hepatocytes. 3,5-T2 prevents and reverts these effects differently in adult and fetal cells 11
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis 11
Extranuclear effects of thyroid hormones and analogs during development: An old mechanism with emerging roles 10
1H-NMR metabolomics reveals a multitarget action of Crithmum maritimum ethyl acetate extract in inhibiting hepatocellular carcinoma cell growth 10
Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease 10
Lactic acid fermentation: A maladaptive mechanism and an evolutionary throwback boosting cancer drug resistance 10
A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells 10
Lipids around the clock: Focus on circadian rhythms and lipid metabolism 10
Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis 10
Dysfunctional mitochondrial bioenergetics sustains drug resistance in cancer cells 9
Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum L 9
Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma 9
Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacy 9
Crithmum maritimum Extract Restores Lipid Homeostasis and Metabolic Profile of Liver Cancer Cells to a Normal Phenotype 9
Changes in gluconeogenesis and intracellular lipid accumulation characterize uremic human hepatocytes ex vivo 9
Effect of fructose and 3,5-diiodothyronine (3,5-T(2)) on lipid accumulation and insulin signalling in non-alcoholic fatty liver disease (NAFLD)-like rat primary hepatocytes 8
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors 8
Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology 8
Membrane receptors and T3 mitogenic effects in hepatocytes during prenatal life 8
Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth 7
Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice 7
3,5,3'-Triiodothyronine (T3) stimulates cell growth through reactive oxygen species (ROS) and PI3K/Akt pathway 7
Short-term effects of thyroid hormones during development: Focus on signal transduction 7
Proliferative non genomic effects of thyroid hormones are mediated by PI3Kinase/Akt activation and ROS production 6
The Edible Plant Crithmum maritimum Shows Nutraceutical Properties by Targeting Energy Metabolism in Hepatic Cancer 6
Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits 6
Totale 326
Categoria #
all - tutte 739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 739


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026326 0 0 0 8 12 13 42 46 153 52 0 0
Totale 326